{Reference Type}: Journal Article {Title}: Evaluation of safety and operative time in tumescent-free robotic nipple-sparing mastectomy: a retrospective single-center cohort study. {Author}: Hwang YH;Han HH;Eom JS;Yoo TR;Kim J;Chung IY;Ko B;Kim HJ;Lee JW;Son BH;Lee SB; {Journal}: Ann Surg Treat Res {Volume}: 107 {Issue}: 1 {Year}: 2024 Jul {Factor}: 1.766 {DOI}: 10.4174/astr.2024.107.1.8 {Abstract}: UNASSIGNED: Tumescent in nipple-sparing mastectomy (NSM) has been reported to increase the risk of necrosis by impairing blood flow to the skin flap and nipple-areolar complex. At our institution, we introduced a tumescent-free robotic NSM using the da Vinci single-port system (Intuitive Surgical, Inc.).
UNASSIGNED: We conducted a retrospective analysis of patients who underwent tumescent-free robotic NSM between October 2020 and March 2023 at Asan Medical Center (Seoul, Korea). Clinicopathological characteristics, adverse events, and operative time were evaluated.
UNASSIGNED: During the study period, 118 patients underwent tumescent-free robotic NSM. Thirty-one patients (26.3%) experienced an adverse event. Five patients (4.2%) were classified as grade III based on the Clavien-Dindo classification and required surgery. The mean total operative time was 467 minutes for autologous tissue reconstruction (n = 49) and 252 minutes for implants (n = 69). No correlation was found between the cumulative number of surgical cases and the breast operative time (P = 0.30, 0.52, 0.59 for surgeons A, B, C) for the 3 surgeons. However, a significant linear relationship (P < 0.001) was observed, with the operative time increasing by 13 minutes for every 100-g increase in specimen weight.
UNASSIGNED: Tumescent-free robotic NSM is a safe procedure with a feasible operative time and few adverse events.